Jack Cuzick
Impact in
- Cancer Research top 0.02%
- Breast Cancer Treatment Studies
- Oncology top 0.02%
- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Cancer Risks and Factors
Papers in
- Oncology 184
- Global Cancer Incidence and Screening 65
- Cancer Risks and Factors 64
- Epidemiology 165
- Cervical Cancer and HPV Research 156
- Co-authors
- Anthony Howell (92 shared papers)Mitch Dowsett (74 shared papers)John Forbes (45 shared papers)Ivana Šestak (88 shared papers)Peter Sasieni (43 shared papers)Wendy Atkin (13 shared papers)Stephen W. Duffy (19 shared papers)Aman U. Buzdar (16 shared papers)
- Journals
- British Journal of Cancer (50 papers)Journal of Clinical Oncology (48 papers)International Journal of Cancer (48 papers)Cancer Research (29 papers)The Lancet (22 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Jack Cuzick
642 papers receiving 47.9k citations
Jack Cuzick's Hit Papers
Peers
Comparison fields: 5 of 217
- Cancer Research 9.6k
- Oncology 14.8k
- Epidemiology 13.1k
- Genetics 7.4k
- Pulmonary and Respiratory Medicine 6.6k
Countries citing papers authored by Jack Cuzick
This map shows the geographic impact of Jack Cuzick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Cuzick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Cuzick more than expected).
Fields of papers citing papers by Jack Cuzick
This network shows the impact of papers produced by Jack Cuzick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Cuzick. The network helps show where Jack Cuzick may publish in the future.
Co-authors
The 25 scholars most cited alongside Jack Cuzick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 656 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer Hit paper breakdown → | 2005 | 1727 |
| 2 | A wilcoxon‐type test for trend Hit paper breakdown → | 1985 | 1660 |
| 3 | Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial Hit paper breakdown → | 2010 | 1167 |
| 4 | Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial Hit paper breakdown → | 2010 | 1128 |
| 5 | A breast cancer prediction model incorporating familial and personal risk factors Hit paper breakdown → | 2004 | 877 |
| 6 | Overview of the European and North American studies on HPV testing in primary cervical cancer screening Hit paper breakdown → | 2006 | 863 |
| 7 | Long-Term Risk of Colorectal Cancer after Excision of Rectosigmoid Adenomas Hit paper breakdown → | 1992 | 806 |
| 8 | Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial Hit paper breakdown → | 2010 | 718 |
| 9 | Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. Hit paper breakdown → | 1994 | 691 |
| 10 | Overview of the main outcomes in breast-cancer prevention trials Hit paper breakdown → | 2003 | 690 |
| 11 | The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women Hit paper breakdown → | 2010 | 588 |
| 12 | Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen Hit paper breakdown → | 2009 | 580 |
| 13 | Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement Hit paper breakdown → | 2009 | 574 |
| 14 | Key steps for effective breast cancer prevention Hit paper breakdown → | 2020 | 565 |
| 15 | Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study Hit paper breakdown → | 2011 | 554 |
| 16 | Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study Hit paper breakdown → | 2010 | 548 |
| 17 | Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer Hit paper breakdown → | 2011 | 548 |
| 18 | Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older Hit paper breakdown → | 2008 | 528 |
| 19 | Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries Hit paper breakdown → | 2008 | 483 |
| 20 | 2008 | 470 |
About Jack Cuzick
Jack Cuzick is a scholar working on Oncology, Epidemiology, Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 656 papers that have together received 49.6k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (156 papers), Breast Cancer Treatment Studies (98 papers), Estrogen and related hormone effects (76 papers), Global Cancer Incidence and Screening (65 papers), Cancer Risks and Factors (64 papers), Prostate Cancer Treatment and Research (43 papers), Genital Health and Disease (39 papers) and BRCA gene mutations in cancer (39 papers). The work is most often cited by research in Cancer Research (9.6k citations), Oncology (14.8k citations), Epidemiology (13.1k citations), Genetics (7.4k citations) and Pulmonary and Respiratory Medicine (6.6k citations). Jack Cuzick has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Anthony Howell, Mitch Dowsett, John Forbes, Ivana Šestak, Peter Sasieni, Wendy Atkin, Stephen W. Duffy, Aman U. Buzdar, Michael Baum and George Terry. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, International Journal of Cancer, Cancer Research and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.